Loading…
Reported covered position: Deputy Chief of Staff, Rep. Kennedy; Legislative Director, Rep. Chandler; Legislative Director, Rep. Driehaus; Legislative Assistant, Rep. Strickland
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Paycheck Protection Program and Health Care Enhancement Act
Client: MAYO CLINIC · Firm: MAYO CLINIC
Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality and Transparency; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Paycheck Protection Program and Health Care Enhancement Act
Client: MAYO CLINIC · Firm: MAYO CLINIC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2020 · fourth_quarter · Q4
Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality and Transparency; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Changes to the immigration status of foreign doctors, students, and patients
Source: Senate LDA
Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality and Transparency; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Paycheck Protection Program and Health Care Enhancement Act
Client: MAYO CLINIC · Firm: MAYO CLINIC
Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; Federal funding for expenses or lost revenues attributable to COVID-19; Disbursements from and repayments to the Provider Relief Fund; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Paycheck Protection Program and Health Care Enhancement Act
Client: MAYO CLINIC · Firm: MAYO CLINIC
Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: MAYO CLINIC · Firm: MAYO CLINIC
Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality and Transparency; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: MAYO CLINIC · Firm: MAYO CLINIC
Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: MAYO CLINIC · Firm: MAYO CLINIC
Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality and Transparency; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: MAYO CLINIC · Firm: MAYO CLINIC
Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; Federal funding for expenses or lost revenues attributable to COVID-19; Disbursements from the Provider Relief Fund; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: MAYO CLINIC · Firm: MAYO CLINIC
Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: MAYO CLINIC · Firm: MAYO CLINIC
Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; Federal funding for expenses or lost revenues attributable to COVID-19; Disbursements from and repayments to the Provider Relief Fund; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: MAYO CLINIC · Firm: MAYO CLINIC
Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: MAYO CLINIC · Firm: MAYO CLINIC
Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality and Transparency; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act
Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality and Transparency; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; Federal funding for expenses or lost revenues attributable to COVID-19; Disbursements from the Provider Relief Fund; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act
Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act
Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; Federal funding for expenses or lost revenues attributable to COVID-19; Disbursements from and repayments to the Provider Relief Fund; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act
Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality and Transparency; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality and Transparency; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; Federal funding for expenses or lost revenues attributable to COVID-19; Disbursements from and repayments to the Provider Relief Fund; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality and Transparency; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act
Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality and Transparency; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; Federal funding for expenses or lost revenues attributable to COVID-19; Disbursements from the Provider Relief Fund; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act
Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act
Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; Federal funding for expenses or lost revenues attributable to COVID-19; Disbursements from and repayments to the Provider Relief Fund; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act
Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality and Transparency; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality and Transparency; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; Federal funding for expenses or lost revenues attributable to COVID-19; Disbursements from and repayments to the Provider Relief Fund; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Reimbursement and coverage issues related to VA health care and Tricare
Reimbursements and lab payments including PAMA and S. 6102, the Verifying Accurate Leading-edge IVCT Development Act of 2020; Regulation of and reimbursements for testing related to COVID-19; Medical research funding; Regulatory relief; Laboratory diagnostic tests; Rural health; Innovation in treatments for COVID-19 including convalescent plasma
Telemedicine technology; New diagnostic tests, Precision medicine; Broadband expansion and Internet access; Privacy and data security and usage
Drug shortages
Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE, Veterans Affairs, Dept of (VA), White House Office
2020 · third_quarter · Q3
Reimbursements and lab payments including PAMA and S. 6102, the Verifying Accurate Leading-edge IVCT Development Act of 2020; Regulation of and reimbursements for testing related to COVID-19; Medical research funding; Regulatory relief; Laboratory diagnostic tests; Rural health; Innovation in treatments for COVID-19 including convalescent plasma
Drug shortages; drug pricing
Changes to the immigration status of foreign doctors, students, and patients
Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality and Transparency; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Reimbursement and coverage issues related to VA health care and Tricare
Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; Federal funding for expenses or lost revenues attributable to COVID-19; Disbursements from and repayments to the Provider Relief Fund; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act
Telemedicine technology; New diagnostic tests, Precision medicine; Broadband expansion and Internet access; Privacy and data security and usage
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE, Veterans Affairs, Dept of (VA), White House Office
2020 · second_quarter · Q2
Reimbursement and coverage issues related to VA health care and Tricare
Funding and operations at the Rochester International Airport
Telemedicine technology; New diagnostic tests, Precision medicine; Broadband expansion and Internet access
Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; Federal funding for expenses or lost revenues attributable to COVID-19; Disbursements from the Provider Relief Fund; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act
Changes to the immigration status of foreign doctors, students, and patients
Reimbursements and lab payments including PAMA and S. 6102, the Verifying Accurate Leading-edge IVCT Development Act of 2020; Regulation of and reimbursements for testing related to COVID-19; Medical research funding; Regulatory relief; Laboratory diagnostic tests; Rural health
Drug shortages; drug pricing; 340B Program
Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE, Veterans Affairs, Dept of (VA), White House Office
2020 · first_quarter · Q1
Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act
Drug shortages; drug pricing; 340B Program
Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act
Reimbursements and lab payments including PAMA and S. 6102, the Verifying Accurate Leading-edge IVCT Development Act of 2020; Regulation of and reimbursements for testing related to COVID-19; Medical research funding; Regulatory relief; Laboratory diagnostic tests; Rural health
Reimbursement and coverage issues related to VA health care and Tricare
Telemedicine technology; New diagnostic tests, Precision medicine; NextGen sequencing
Funding opportunities and planned improvements for the Rochester International Airport
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE, Veterans Affairs, Dept of (VA), White House Office
2019 · fourth_quarter · Q4
Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality;
Drug Shortage; Drug Pricing; Opioid Epidemic; 340B Program
Telemedicine; Laboratory Medicine payment and oversight
PAMA (Lab Payments); Medical Research Funding; Regulatory Relief; Laboratory Diagnostic Tests; Rural Health
Telemedicine technology; New Diagnostic tests, Precision Medicine; NextGen Sequencing
Reimbursement and coverage issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)